Sign In
Buy JNJ
$239.08
+7.79 (+3.37%)
At Close: Jun 23, 2026
Making Sense of the Early Q4 Results: Is An Earnings Cliff Coming?
03:48pm, Friday, 20'th Jan 2023
By the end of this week, we will have seen quarterly results from about 28% of all S&P 500 members and will have a very good sense of whether the earnings-cliff narrative has started unfolding or been
Better 2023 Dividend Stock: AbbVie Or Johnson & Johnson?
02:14pm, Friday, 20'th Jan 2023
My main thesis is to explain why AbbVie Inc. remains my top 2023 dividend stock in the healthcare space despite its near-record stock prices. The thesis is best illustrated by comparison and contrast
Earnings Previews: Johnson & Johnson, 3M, Verizon
11:38am, Friday, 20'th Jan 2023
In late morning trading Friday, the Dow Jones industrial average traded up 0.27%, the S&P 500 up 0.71% and the Nasdaq up 1.16%.
J&J (JNJ) to Begin Q4 Earnings Season for Pharma Sector
09:47am, Friday, 20'th Jan 2023
Growth in J&J's (JNJ) Pharma unit is expected to have been driven by drugs like Darzalex and Stelara. In the MedTech segment, continued recovery in worldwide procedure volume should drive sales.
3 Top Passive-Income Stocks to Own in 2023
02:00pm, Thursday, 19'th Jan 2023
These stocks can add safety and growth to your portfolio.
3 Safe Stock Bets for an Unpredictable Market
11:29am, Thursday, 19'th Jan 2023
Last year was rough for the stock market, but that doesn't mean that all stocks should be avoided. Many names have fallen sharply over the last 18 months, and that has given investors an opportunity t
J&J (JNJ) Discontinues HIV Vaccine Phase III Mosaico Study
09:02am, Thursday, 19'th Jan 2023
J&J (JNJ) discontinues phase III study on its investigational HIV vaccine regimen, which shows that the candidate lacks efficacy in preventing HIV.
Johnson & Johnson Breakout Breaks Down: Can Earnings Boost Stock?
04:00am, Thursday, 19'th Jan 2023
Johnson & Johnson stock has been struggling to break out of a correction. It formed a cup-shaped pattern that appeared to add a handle but broke down last week.
J&J discontinues HIV trial in latest setback to vaccine pursuit
02:57am, Thursday, 19'th Jan 2023
Johnson & Johnson (NYSE:JNJ)'s wholly-owned pharmaceutical company Janssen Pharmaceuticals and its global research partners have discontinued their Phase 3 Mosaico study of Janssen's investigational
10 Biggest Companies Reporting Earnings in the 4th Week of Jan 2023
10:52pm, Wednesday, 18'th Jan 2023
The fourth quarter earnings season is always the most important because it reveals the full year performance of the companies as well.
J&J's HIV vaccine fails Phase 3 clinical trial
12:54pm, Wednesday, 18'th Jan 2023
Johnson & Johnson's JNJ, -1.17% experimental HIV vaccine is safe but not effective, and the late-stage study will be discontinued as a result of that finding, federal researchers said Wednesday. J&J's
Blue-Chip Stocks And Red Flags - Things To Consider In Your Due Diligence
11:35am, Wednesday, 18'th Jan 2023
Investing in blue-chip companies that pay dividends and relentlessly focusing on reinvesting the proceeds is a proven strategy for reliable long-term returns. But what about the occasional black swan?
What To Expect From Johnson & Johnson's Q4?
11:00am, Wednesday, 18'th Jan 2023
The company will likely see a steady rise in revenue led by continued market share gains for its drugs - Darzalex, Stelara, Erleada, and Tremfya.
3 Dividend Stocks For Passive Income
09:16am, Wednesday, 18'th Jan 2023
I'm aiming to grow my passive income this year through adding these safe value stocks to my portfolio that have strong dividend yields.
5 Warren Buffett Stocks to Buy Hand Over Fist in 2023
05:30am, Wednesday, 18'th Jan 2023
These stocks deliver a lot of the elements Buffett loves most.
